Peer Reviewed

editorialoffice@confseries.net   +44 7897-071619

Follow Us:

Journal of Pharma and Drug Innovation

Frequency : Quarterly
Manuscript Guidelines Journals Membership
Editorial & Review Timeline
3 - 9 Days Initial Quality Review
14 Days Peer Evaluation Summary
80% Final Acceptance Rate After Peer Review
35 - 45 Days Complete Editorial Processing Time

Prof Mohammad Amjad Kamal nbnvnvn

ph.D

  • Affiliation: Adjunct Assistant Professor
  • Department: Dept Faculty of Specific Education
  • University: Guangzhou University of Chinese Medicine
  • Email: sravyapadalaaad13@mail.com
  • Country: United Kingdom

biography

Indexed In

Google Scholar Open J Gate Genamics JournalSeek RefSeek Hamdard University EBSCO A-Z OCLC- WorldCat Publons Geneva Foundation for Medical Education and Research Euro Pub

Flyer Image

Flyer Image

Journal Highlights

Cutting-Edge Therapeutic Innovations Advanced Computational Drug Design Translational Pharmaceutical Research Smart and Targeted Delivery Platforms Synthetic and Green Chemistry Approaches Global Health and Access to Medicines Personalized and Precision Medicine Emerging Trends in Biologics and Immunotherapy Pharmaceutical Policy, Ethics, and Education

Recommended Journals

Journal of Pharma and Drug Innovation Journal of Neuroscience and Clinical Neurology Journal of Targeted Oncology Research Journal of Cardiovascular Care and Research

About Confseries

Confseries is a platform for publishing high-quality research journals across various disciplines. We aim to provide a seamless experience for authors, reviewers, and readers.

Useful Links

Home Submit Manuscript Archive Terms and Conditions Contact

Contact Information

+44-7897071619

pharma@confseries.net

support@confseries.com

Quick Links

Submit

Archive

Contact

Editors

Aims

Guidelines

© Copyright All rights reserved by Confseries